News
Novo Nordisk, the maker of Ozempic and Wegovy weight-loss drugs, just regained the title as Europe’s most valuable company ...
Wegovy maker Novo Nordisk is moving its investigational amycretin asset into late-stage weight loss trials starting early ...
Drugmaker Novo Nordisk is once again Europe's largest company by market capitalisation, rising above German software firm SAP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback